Power Law company profile

Rigel Pharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 1996 · IPO 2000 Thoroughbred

Small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases

Valuation

$433M

Market cap · May/2026

Revenue

$294M

Latest reported FY

EBITDA

$104M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Rigel Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Frazier Healthcare Partners

Series B+ 1 investor entered at this stage

NEA

Rigel Pharmaceuticals mafia

Startups founded by Rigel Pharmaceuticals alumni

Former Rigel Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

Shinobi TherapeuticsEst. 2023

Donald PayanUnited States

Immune-Onc TherapeuticsEst. 2016

Charlene LiaoUnited States

Signal score66

Cognition TherapeuticsEst. 2007

SCSusan CatalanoUnited States

Signal score66

BiPar SciencesEst. 2002

VPValeria Ossovskaya, PhDUnited States

Book a demo to explore the full alumni network →

Global footprint

Where Rigel Pharmaceuticals has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States97.3%

🇮🇳 India0.7%

🇮🇹 Italy0.7%

🇬🇭 Ghana0.7%

4 countries shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States47.3%

🇨🇦 Canada20%

🇬🇧 United Kingdom17.3%

🇮🇳 India13.6%

Top 4 markets shown

Market sentiment

What the market is saying about Rigel Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Rigel Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rigel Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles